These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2713555)
1. Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia. Favrot M; Philip I; Combaret V; Pavone E; Bouffet E; Biron P; Philip T Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():202-4. PubMed ID: 2713555 [No Abstract] [Full Text] [Related]
2. [Monoclonal antibody and purging]. Ueda R; Morishima Y Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016 [No Abstract] [Full Text] [Related]
3. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse. Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984 [TBL] [Abstract][Full Text] [Related]
4. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720 [TBL] [Abstract][Full Text] [Related]
5. Perspectives of monoclonal antibodies in the acute leukaemias. Hervé P; Wijdenes J; Racadot E Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():198-201. PubMed ID: 2653503 [No Abstract] [Full Text] [Related]
6. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia. Bai Y; Piao XH; Luo QL; Mao BZ Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055 [TBL] [Abstract][Full Text] [Related]
7. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells. Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445 [No Abstract] [Full Text] [Related]
8. Autologous bone marrow transplantation after in vitro purging with monoclonal antibodies and complement in acute lymphoblastic leukemia. Perez-Oteyza J; Larana JG; Brieva J; Roldan E; Odriozola J; Maldonado M; Otheo E; Munoz A; Bootello A; Navarro JL Prog Clin Biol Res; 1992; 377():163-8. PubMed ID: 1438412 [No Abstract] [Full Text] [Related]
9. Linking the hematopoietic microenvironment to imatinib-resistant Ph+ B-ALL. Dorshkind K; Witte ON Genes Dev; 2007 Sep; 21(18):2249-52. PubMed ID: 17875661 [No Abstract] [Full Text] [Related]
10. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement. Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594 [TBL] [Abstract][Full Text] [Related]
11. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia. Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR Year Immunol; 1993; 7():90-5. PubMed ID: 7690510 [No Abstract] [Full Text] [Related]
13. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts. Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926 [No Abstract] [Full Text] [Related]
14. Purging of bone marrow with a cocktail of monoclonal antibodies (VIB-pool) for autologous transplantation. Zintl F; Reiners B; Thränhardt H; Hermann J; Fuchs D; Prager J Haematol Blood Transfus; 1987; 31():89-91. PubMed ID: 3327792 [No Abstract] [Full Text] [Related]
15. Purging with 4-hydroperoxycyclophosphamide combinations. Jones RJ; Miller CB; Rowley SD Prog Clin Biol Res; 1992; 377():1-9; discussion 10-1. PubMed ID: 1438406 [No Abstract] [Full Text] [Related]
16. Reply to Gaipa et Al. van der Sluijs-Gelling AJ; van der Velden VH; Roeffen ET; Veerman AJ; van Wering ER Leukemia; 2005 Oct; 19(10):1858. PubMed ID: 16107890 [No Abstract] [Full Text] [Related]
17. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children]. Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579 [TBL] [Abstract][Full Text] [Related]
18. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413 [TBL] [Abstract][Full Text] [Related]
19. Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro. Bieber MM; Twist CJ; Bhat NM; Teng NN Pediatr Blood Cancer; 2007 Apr; 48(4):380-6. PubMed ID: 16421902 [TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic modulation in childhood precursor-B-ALL can be mimicked in vitro and is related to the induction of cell death. van der Sluijs-Gelling AJ; van der Velden VH; Roeffen ET; Veerman AJ; van Wering ER Leukemia; 2005 Oct; 19(10):1845-7. PubMed ID: 16107891 [No Abstract] [Full Text] [Related] [Next] [New Search]